NEW YORK, April 29 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has agreed to sell $1.6 billion of senior unsecured notes: $600 million in aggregate principal amount of 5.450% notes due May 1, 2018 and $1 billion in aggregate principal amount of 6.125% notes due May 1, 2038 in an underwritten public offering.
Banc of America Securities LLC, J.P. Morgan Securities Inc., and Morgan Stanley are acting as representatives of the underwriters.
Bristol-Myers Squibb intends to use the net proceeds from the offering to finance the repayment of its $400 million principal amount of the 4.00% Notes due August 2008, to finance redemptions of its $1.2 billion principal amount of Floating Rate Convertible Debentures due 2023 at the option of holders in 2008 and general corporate purposes. The offering is expected to close on May 1, 2008.
The prospectus supplement and accompanying prospectus related to the
offering of the notes may be obtained by contacting one of the following
Banc of America Securities, LLC
Capital Markets Operations
100 West 33rd Street, 3rd Floor
New York, NY 10001
J.P. Morgan Securities Inc.
270 Park Avenue, 8th Floor
New York, NY 10017
Morgan Stanley and Company, Inc.
180 Varick Street 2/F
New York, NY 10014
Attention: Prospectus Department
This press release contains "forward-looking statements" as that term
is defined in the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are based on current expectations and in
|SOURCE Bristol-Myers Squibb Company|
Copyright©2008 PR Newswire.
All rights reserved